Precision BioSciences Inc (DTIL)
8.36
-0.06
(-0.71%)
USD |
NASDAQ |
Nov 08, 16:00
8.36
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Revenue (TTM): 75.10M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 75.10M |
| June 30, 2024 | 87.64M |
| March 31, 2024 | 57.53M |
| December 31, 2023 | 48.73M |
| September 30, 2023 | 52.29M |
| June 30, 2023 | 46.53M |
| March 31, 2023 | 30.56M |
| December 31, 2022 | 25.10M |
| September 30, 2022 | 20.84M |
| June 30, 2022 | 37.51M |
| March 31, 2022 | 102.50M |
| December 31, 2021 | 115.53M |
| Date | Value |
|---|---|
| September 30, 2021 | 118.04M |
| June 30, 2021 | 101.36M |
| March 31, 2021 | 33.64M |
| December 31, 2020 | 24.28M |
| September 30, 2020 | 21.96M |
| June 30, 2020 | 19.46M |
| March 31, 2020 | 23.77M |
| December 31, 2019 | 22.24M |
| September 30, 2019 | 20.66M |
| June 30, 2019 | 18.33M |
| March 31, 2019 | 14.82M |
| December 31, 2018 | 10.88M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
19.46M
Minimum
Jun 2020
118.04M
Maximum
Sep 2021
53.23M
Average
42.02M
Median
Revenue (TTM) Benchmarks
| Assembly Biosciences Inc | -- |
| TG Therapeutics Inc | 264.79M |
| Protagonist Therapeutics Inc | -- |
| Alector Inc | 61.51M |
| Entrada Therapeutics Inc | 215.23M |